BiotechTube
Home/Tasman Therapeutics/Lisa Craigie
LC

Lisa Craigie

Chief Legal and Commercial Officer

Tasman Therapeutics

Therapeutic Areas

PsychiatryTreatment-Resistant DepressionMood Disorders

Tasman Therapeutics Pipeline

DrugIndicationPhase
R-107Treatment-Resistant Depression (TRD)Phase 3

Leadership Team at Tasman Therapeutics

DB
Dan Browne
Chief Executive Officer
DP
Dr. Peter Surman
Chief Scientific Officer
KD
Kent Durbin
Chief Financial Officer
PP
Professor Paul Glue
Clinical Advisory Board Chair & Chief Medical Officer
View full Tasman Therapeutics profile